Some two billion possible agents are going to be tested during the world’s largest computer-aided screening project. Styrian research is…
EOSS Technologies is supporting the government in Montenegro in the extensive measures to combat the Corona pandemic. With a donation…
The search for effective drugs against the coronavirus is ongoing worldwide – also in the BSL3 high-security laboratory in Graz.…
Since the beginning of April, EOSS Technologies has been the largest shareholder in the Austrian drug producer Sanochemia Pharmazeutika, with…
Increasingly sophisticated applications of artificial intelligence dominate everyday life and industry. Styrian magazine Spirit of Styria explains why AI is…
With “Drug and Enzyme Discovery” the Styrian start-up Innophore has already gained attention outside the European borders in recent years.…
In the context of the COVID-19 pandemic, EOSS companies in the Lifescience division are playing an increasingly important role internationally.…
Sanochemia is to contribute to the security of supply of pharmaceuticals in the future. According to Thomas Erkinger, this requires…
Merger in the European pet market By taking a substantial stake in the Bavarian company Mühldorfer Nutrition AG, EOSS Technologies…
Medovis Healthcare advanced to become one of the most important suppliers of MNS masks, FFP2 masks and protective jackets in…
With the enzyme and drug discovery platform Catalophore and the Human Cavitom Project for the identification of active ingredients for…
